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A B S T R A C T
Bovine leukaemia virus (BLV) proteins gp51, which are serving as antigens for speciﬁc antibodies against BLV
proteins (anti-gp51), were applied as biological recognition part in the design of immunosensor devoted for the
determination of anti-gp51. The eﬃciency of the immobilization of BLV proteins gp51 on ZnO nanorod (ZnO-
NR) modiﬁed glass (ZnO-NR/glass) surface was evaluated. The formation of antigen-antibody complex on the
ZnO/glass modiﬁed by the BLV proteins gp51 (gp51/ZnO-NR/glass) was investigated by the determination of
changes in ZnO photoluminescence. The applicability of gp51/ZnO-NR/glass in the design of photoluminescence
based immunosensor was evaluated. Bovine serum albumin (BSA) was applied for the modiﬁcation of sensing
gp51 layer in order to form gp51&BSA layer with advanced selectivity. Polyallylamine hydrochloride (PAH) was
applied in order to improve the immobilization of gp51 and BSA based sensing layer (gp51&BSA) on the surface
of ZnO-NR/glass. PAH was applied during the formation of gp51&BSA/PAH/ZnO-NR/glass structure. Some
aspects of the mechanism of interaction between biomolecules (gp51, BSA and anti-gp51) and ZnO-NR during
the preparation and action of gp51&BSA/ZnO-NR/glass- and gp51&BSA/PAH/ZnO-NR/glass-based im-
munosensors have been discussed.
1. Introduction
Express determination of retroviral infections among humans and
animals is an important global problem. Bovine leukemia virus (BLV)
induces one of several recently known retroviral infections, which af-
fects cattle all over the world and is endemic in many dairy herds [1].
Cattle of all ages may be infected by BLV but the most of them might be
infected soon after the birth by ingestion of milk from an infected cow.
Therefore the main way to prevent the spread of diseases caused by
retroviral infection is the timely diagnosis [2]. Recently used BLV de-
tection methods are time- and labor-consuming and therefore they do
not meet recent requirements. In order to improve diagnosis a number
of diﬀerent BLV infection detection methods were developed, including
polymerase chain reaction [3] and diﬀerent types of the immunological
methods such as enzyme-linked immunosorbent assay, agar gel im-
munodiﬀusion, radioimmune assay, immunoblot test [4,5], etc. The
traditional immunological methods have high speciﬁcity and sensi-
tivity, but the most of them are time consuming and/or require some
additional expensive materials, such as the labeled antibodies [6]. Be-
cause BLV is one of the most common infectious of cattle and is endemic
in many dairy herds, thus control and eradication programs based on
fast, simple, and sensitive BLV detection method are highly desirable.
These requirements can be successfully solved using immunosensors
[7–10].
Practical application of electrochemical immunosensors, even if
they demonstrate high sensitivity to analyte and are less sensitive to the
non-speciﬁc adsorption of interfering materials, still have several
drawbacks: (i) sometimes additional redox mediators are required in
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order to generate amperometric response, (ii) the signal of such devices
depends on characteristics of aliquot (e.g. ionic strength, pH, etc), (iii)
the regeneration of surface in order to use it for multiple analyte de-
tection is not always successful [6,7,11,12]. Therefore, in some cases
label-free immunosensors are more preferable. Several surface plasmon
resonance (SPR) [7], optical ellipsometry [8], acoustic [9] and photo-
luminescence (PL) [13] based BLV sensors were developed. Most of
above-mentioned sensors are optical, where metal and metal oxide
based structures are applied. Some metal oxide based nanorods can
provide a possibility to detect analytical signal of immunosensor di-
rectly (without the usage of additional reagents) and rapidly (within
3–5minutes), inexpensively (cost of single analysis is less as a one US
dollar) [14]. Among many metal oxides zinc oxide (ZnO) also has at-
tracted interest of biosensorics related researches due to suitable
semiconducting properties [15], which are based on wide and direct
optical band gap (3.3 eV), high exciton binding energy (˜60meV) and
possibility to tune a band gap in the range from 2.1 to 3.5 eV. Because
of here mentioned unique properties the ZnO is regarded as one of the
most prospective materials for photonics, optoelectronics and bio-
sensorics [15–17]. The wurtzite-based ZnO nanorods (NRs) showed
high photoluminescence in UV range (370–390 nm), which is related to
excitonic emission band [18] and such NRs have been used for PL based
detection of Salmonella [18]. Additionally, ZnO nanorods with the layer
of the immobilized antibodies were successfully used for interdigitated
capacitive immunosensors [19], for aptamers [20] and lipid ﬁlms-based
electrochemical sensors [21], and some other analytical systems.
Recent developments in optoelectronics oﬀer LEDs with output
power of 0.4–1mW, which are in the interest of biosensorics as low
power intensity light source suitable for excitation of photo-
luminescence. However traditional detection part of the based bio-
sensor consist of monochromator and photomultiplier, which are re-
quired in order to enhance the low intensity signal, what makes the cost
of the detection system quite high. This drawback can be solved by the
application of optical ﬁber based technique [22]. Recently, we have
developed an ﬁber optic-based system based on photoluminescence
measurements suitable for biomedical applications [22]. It is low cost,
portable, computer driven technique. Despite of this, the optical ﬁber
system has lower spectral resolution comparing to the traditional
methods, what is signiﬁcant drawback during intensity measurements
[22].
In this paper we have evaluated the application of ZnO nanorods
(ZnO-NRs) in the design of optical ﬁber based photoluminescence im-
munosensor, which is dedicated for the determination of speciﬁc anti-
bodies produced in cattle as humoral immune response against BLV-
antigens that mainly consist of protein gp51.
2. Experimental
2.1. Materials
BLV proteins gp51, and two cattle serums (i) ‘BLV-positive’, which
has speciﬁc antibodies against BLV proteins, and (ii) ‘BLV-negative’,
which is free from speciﬁc antibodies against BLV proteins gp51, all
were purchased from "Leykonad", Poltava, Ukraine. Glass slides, poly-
allylamine hydrochloride (PAH), butanol and bovine serum albumin
(BSA) were obtained from Sigma-Aldrich (St. Louis, USA). All solutions
were prepared using distilled and deionized water (Milli Q-plus-
Millipore system).
2.2. Preparation and characterization of ZnO-NRs sensitive layer
ZnO nanorod powder was synthesized as reported previously [22].
Colloidal suspension of ZnO-NRs in butanol (concentration 1mg/ml)
was prepared. The solution of ZnO-NRs (20 μL) was deposited on the
cleaned glass substrate in order to form ZnO-NRs layer on the glass
surface. The samples were dried at room temperature and annealed in
muﬄe furnace at 450 °C in air for 3 h. Scanning electron microscopy
(SEM) imaging of the prepared samples was performed by Hitachi
S4800 SEM (Mannheim Oﬃce) (Japan).
Optical properties of the ZnO-based nanorods were studied by PL
spectroscopy. Nitrogen laser of λ=337 nm LGI-21 from Polyaron
(Moscow, Russia) with 0.4 mW output power was used as an excitation
source. The PL spectra were studied by optical ﬁber spectrometer,
HR2000+ from Ocean Optics (Dunedin, USA) in the wavelength range
of 360–420 nm.
Raman spectrometer ALFA300R from Witek (Ulm, Germany) with
532 nm excitation laser source was used for transmittance Raman
measurements. The Raman spectra of the samples were recorded in the
range of 50–2000 cm−1.
2.3. Functionalization of the ZnO-NRs/glass by proteins and the evaluation
of immunosensor response
BLV proteins gp51, which served as an antigen (Ag) for anti-gp51
antibodies, were used in the development of biological recognition part
of immunosensor. BLV proteins were immobilized on ZnO-nanorod
(ZnO-NR) modiﬁed glass (ZnO-NR/glass) surface. The functionalization
procedures, which were applied for modiﬁcation of PL-based trans-
ducer surface are shown in Fig. 1.
The ZnO-NR/glass slides were washed with ethanol, dried and then
rinsed with physiological (0.85%) solution of NaCl. Initial BLV protein
gp51, which was acting as antigen (Ag) in this bioanalytical system,
containing sample was diluted to the concentration of 0.5 mg/L with
the solution of NaCl and such diluted solutions were incubated on the
surface of ZnO-NR/glass substrates for 20min in order to get layered
gp51/ZnO-NR/glass structure. Then gp51/ZnO-NR/glass surface was
rinsed with the physiological solution of NaCl and dried in air at room
temperature. In order to prevent non-speciﬁc adsorption of proteins,
the gp51/ZnO-NR/glass slides were incubated in 0.5mg/mL solution of
BSA for 20min (Fig. 1A). The PL-spectra were registered before and
after each incubation step.
The deposition of polyallylamine hydrochloride (PAH) and investigation
of modiﬁed surfaces. In order to get PAH-modiﬁed ZnO-NR/glass (PAH/
ZnO/glass) aqueous solution of 20 μg/mL of PAH was incubated for
20min on the surface of ZnO-NR/glass substrate and then it was wa-
shed with distilled water, and dried in air at room temperature. The
immobilization of gp51 and BSA on the PAH/ZnO-NR/glass was per-
formed similarly to the procedure, which is described for ZnO-NR/glass
substrate (Fig. 1B) and in such way gp51&BSA/PAH/ZnO-NR/glass-
based immunosensing structure was formed. PL-spectra were recorded
before and after each modiﬁcation step.
During the determination of antibodies against BLV proteins gp51
(gp51), the gp51/ZnO-NR/glass and gp51/PAH/ZnO-NR/glass samples
were incubated for 20min in ‘BLV-positive’ cattle serum containing
anti-gp51 and in ‘BLV-negative’ cattle serum aliquot not-containing
anti-gp51. Before the incubation both ‘BLV-positive’ and ‘BLV-negative’
Fig. 1. Scheme of gp51 protein and BSA immobilisation on the surface of ZnO-
NR/glass (A) and on – PAH/ZnO-NR/glass (B).
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serums were diluted with physiological solution of NaCl in following
ratios: c1= 1:1,000,000 (10−6 a.u.), c2= 1:100,000 (10-5 a.u.),
c3= 1:10,000 (10-4 a.u.), c4= 1:1000 (10-3 a.u.) and c5= 1:100 (10-2
a.u).
After the incubation in the tested serums, the surfaces were washed
and dried. The PL-spectra were recorded before and after each in-
cubation step.
Additional control measurements have been performed by the in-
cubation of PAH/ZnO-NR/glass, which was not functionalized by gp51
proteins, in ‘BLV-positive’ and only ‘BLV-negative’ cattle serums. The
corresponding PL spectra have been recorded before and after the in-
cubation in ‘BLV-positive’ and ‘BLV-negative’ cattle serums.
Each analytical measurement was performed at least 3 times and the
average of registered signals is presented.
3. Results and discussion
3.1. Characterization of ZnO nanorods
A SEM image of the ZnO-NRs deposited on a glass substrate (ZnO-
NR/glass) is shown in Fig. 2A,B. From the image it is seen that the ZnO-
nanorods had random orientation (Fig. 2B). The distribution of the
diameter of formed ZnO-NRs is 60–100 nm and the length is
300–900 nm as reported in [22].
Raman spectrum of ZnO-NR/glass-based substrate is shown in
Fig. 3. The Raman peak at 383 cm−1 correspond to A1(TO) polar optical
phonon mode, peak at 439 cm−1, which is assigned to E2 (high) non-
polar mode, and peak at 332 cm−1 that can be assigned to E2high- E2low
mode [23]. Raman peaks, which are observed between 570 and
650 cm−1, can be associated with structural disorders, such as oxygen
vacancies, Zn interstitial and their combination [18]. Sharp Raman E2
mode and SEM images approve the perfect wurtzite structure of ZnO
nanorods.
3.2. Testing of optical immunosensor based on ZnO-NRs
As it was previously reported by Viter et al. [18], UV emission band
was dominant in PL-spectra of ZnO-NRs and VIS emission band was
meaningless comparing to the UV band. Thus, the main attention to
changes in UV emission band of ZnO-NRs was paid during the evalua-
tion of developed immunosensor response.
After the immobilization of gp51 and blocking of gp51/ZnO-NR/
glass and gp51/PAH/ZnO-NR/glass by BSA gp51&BSA/ZnO-NR/glass
and gp51&BSA/PAH/ZnO-NR/glass structures were formed. Both gp51
&BSA/ZnO-NR/glass and gp51&BSA/PAH/ZnO-NR/glass structures
were analyzed by photoluminescence spectroscopy, in the same way as
it was reported by Viter et al. [18] and Syshchyk et al. [24]. The re-
gistered PL-spectra are presented in Fig. 4.
PL-spectra of bare ZnO-NR/glass substrate have signiﬁcantly
changed after the immobilization of gp51 and BSA. Particularly, the
immobilization of gp51 resulted in the decrease of the PL-intensity,
whereas modiﬁcation of gp51/ZnO-NR/glass by BSA resulted in the
increase of the PL-intensity (Fig. 4A). The formation of PAH-polyelec-
trolyte layer on the ZnO-NR/glass surface (PAH/ZnO-NR/glass) re-
sulted in the increase of the photoluminescence (Fig. 4B). The im-
mobilization of gp51 and BSA on the PAH/ZnO-NR/glass surface
resulted in the formation of gp51&BSA/PAH/ZnO-NR/PAH structure.
During the modiﬁcation step of PAH/ZnO-NR/glass by gp51 increased
PL was registered for gp51&BSA/PAH/ZnO-NR/glass and after next
modiﬁcation step by BSA decrease of the PL intensity was observed for
gp51&BSA/PAH/ZnO-NR/glass structure (Fig. 4B). The diﬀerences of
PL-spectra during the adsorption of gp51 and BSA proteins on the PAH
modiﬁed ZnO-NR/glass- and not modiﬁed PAH/ZnO-NR/glass-based
substrates is attributed to electrostatic eﬀect of PAH.
The formation of bioselective layers (gp51 or gp51&BSA) is aﬀected
by electrostatic interaction between proteins (gp51 and BSA) and the
ZnO-NR/glass substrate. This electrostatic interaction is inﬂuencing PL-
spectra of modiﬁed ZnO-NR/glass substrate, which leads to the change
of surface potential of ZnO [15,18,25–27]. It is known, that UV band of
ZnO-NRs can be tailored by the variation of depleted layer width, which
is controlling photo-induced charge separation in near interphase be-
tween ZnO and solution or air [25]. As it is reported previously in our
recent reviews on metal oxide biosensors, there is still no very solid
explanation for the mechanism of interaction between biomolecules
and ZnO surface [15,18,23,28]. Therefore, the interaction mechanism
at some extent can be assessed by the evaluation of direct and polymer
assisted immobilization of biomolecules on the ZnO-NRs surface.
When the gp51 and BSA molecules are adsorbed on the surface of
ZnO-NRs they can mostly interact with the surface of ZnO-NRs via
electrostatic interaction and via Van-der-Waals forces [6]. Isoelectric
points (IEP) of ZnO, BSA and BLV-antigens are at pH 9.3, pH 4.7 and pH
6.4–6.6, respectively [18,29,30]. Based, on the fact that the pH in here
used water solution of NaCl was 6.2–6.5, we can suppose that at this pH
BSA proteins are charged negatively and gp51 proteins are at neutrally
Fig. 2. SEM images of deposited ZnO nanorods with diﬀerent magniﬁcation.
Fig. 3. Raman spectrum of ZnO-NRs deposited on glass substrate.
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charged state, whereas ZnO-NRs surface after the adsorption of gp51
proteins is charged positively. Therefore, due to electrostatic interac-
tion the adsorption of gp51 proteins on bare ZnO-NR/glass substrate
exhibited opposite eﬀect to the intensity of PL-signal of ZnO-NRs in
comparison to that induced by BSA proteins.
Polyelectrolyte – PAH – is also involved into variation of ZnO sur-
face charge. PAH is supposed to provide better electrostatic attraction
of gp51 to the ZnO-NRs surface via the polycationic layer of PAH
[31–34] and the formation of polyelectrolyte layer on the ZnO surface
resulted the increase of ZnO photoluminescence due to the passivation
of centers, corresponding to non-radiative recombination or/and the
decrease of the depletion layer in surface region of ZnO-NRs.
The surface of PAH layer has been charged positively [30]. There-
fore, BLV-antigens have been bound to PAH via negatively charged
groups such as−COO−,−COH,−OH, etc. The increase of PL the most
probably is related to electrostatic interactions between ZnO-NRs, PAH
and BLV-antigens, because gp51 are not able to transfer charge to the
ZnO-NRs.
Before the investigation of bovine serum samples the response of
immunosensor towards ‘BLV-negative’ and ‘BLV-positive’ (anti-gp51
antibodies containing) serum probes were tested (Fig. 5A,B). From the
data obtained for ZnO-NR/glass samples, the non-speciﬁc adsorption of
materials, which are present in the ‘BLV-positive’ probe, results in the
decrease of PL-signal, whereas the non-speciﬁc adsorption of materials,
which are present in the ‘BLV-negative’ probe, results in to the increase
of the PL-signal (Fig. 5A). Non-speciﬁc interaction of ‘BLV-positive’ and
‘BLV-negative’ probes with PAH/ZnO-NR/glass surface resulted in the
increase of the PL-signal intensity (Fig. 5B). Comparing the changes of
ZnO-NR/glass- and PAH/ZnO-NR/glass-based immunosensor signals
during the functionalization by proteins we can assume that the for-
mation of PAH/ZnO-NR/glass structure, resulted in the change of in-
teraction between the PL-centers of ZnO-NRs and proteins (gp51 and
BSA), which are forming bioselective layer (Figs. 4 and 5) [18,24].
The interaction of ‘BLV-negative’ probe with the surface of bare
ZnO-NR/glass structure resulted in the increase of the PL-signal. The
interaction of ‘BLV-negative’ probe with PAH/ZnO-NR/glass structure
resulted in the increase of the PL signal.
The responses of biofunctionalized gp51&BSA/ZnO-NR/glass and
gp51&BSA/PAH/ZnO-NR/glass structures towards ‘BLV-positive’ and
‘BLV-negative’ aliquots are shown in Figs. 6 and 7, respectively. The
decrease of the PL-signal was observed when both, above mentioned,
gp51-modiﬁed structures were incubated in ‘BLV-positive’ aliquots. It is
worth to mention that after speciﬁc interaction observed signal, which
is based on PL quenching, is more signiﬁcant than the signal, which is
based on non-speciﬁc interaction of ‘BLV-positive’ aliquot with ZnO-
NR/glass and PAH/ZnO-NR/glass structures, which were not modiﬁed
by gp51 that are speciﬁcally binding anti-gp51 antibodies present in
‘BLV-positive’ aliquot. Both gp51&BSA/ZnO-NR/glass and gp51&BSA/
PAH-ZnO-NR/glass structures after the incubation in ‘BLV-negative’
aliquots showed the increase of the PL-signal, while after the incubation
in ‘BLV-positive’ aliquots the signals of both (gp51&BSA/ZnO-NR/glass
and gp51&BSA/PAH-ZnO-NR/glass) structures has decreased.
The response of developed immunosensors was calculated according
to the following equation, which was reported earlier [18,35]:
S=1–Inorm (C), (1)
where Inorm(C) is a normalized PL intensity after the treatment of gp51&
BSA/ZnO-NR/glass structure with ‘BLV-positive’ or ‘BLV-negative’
probe at corresponding probe concentration C.
The calibration curves of ZnO-NR/glass and PAH/ZnO-NR/glass
based structures towards ‘BLV-positive’ and ‘BLV-negative’ BLV probes
are shown in Fig. 8A and B, respectively. In presented results some
diﬀerences of PL-signal of these two ZnO-NR/glass and PAH/ZnO-NR/
glass based structures after interaction with ‘BLV-positive’ and ‘BLV-
negative’ probes are observed.
The incubation of gp51&BSA/ZnO-NR/glass and gp51&BSA/PAH/
ZnO-NR/glass based structures in ‘BLV-positive’ aliquots resulted in the
decrease of PL due to interaction of immobilized gp51 proteins with
anti-BLV antibodies. Form shifts of PL-spectra maximums we can con-
clude that the dominating eﬀect on photoluminescent centres of ZnO-
NRs based on electrostatic interaction between ZnO-NRs and im-
mobilized gp51 in similar way as it was determined in the case of in-
teraction between TiO2 and gp51 [36].
We can conclude that no signiﬁcant changes between 1:1,000,000
and 1:100,000 dilution of probes were observed for gp51&BSA/ZnO-
NR/glass based immunosensor (Fig. 8A), whereas for immunosensor,
which was based on gp51&BSA/PAH ZnO-NR/glass, the PL-signal at the
Fig. 4. PL-spectra of bare ZnO-NR/glass sub-
strate (A): 1 – ZnO-NRs/glass, 2 – gp51/ZnO-
NRs/glass, 3 – gp51&BSA/ZnO-NRs/glass; and
PAH-modiﬁed ZnO nanorods (B): 1 – ZnO-
NRs/glass, 2 – PAH/ZnO-NRs/glass, 3 – gp51/
PAH/ZnO-NRs/glass, 4 – gp51&BSA/PAH/
ZnO-NRs/glass after the immobilization of
BLV-antigen (gp51) and the blockage of re-
maining free binding sites with BSA. The
curves are average of 3 measurements at each
stage of modiﬁcation.
Fig. 5. Control measurements of ‘BLV-positive’
and ‘BLV-negative’ serum probes on ZnO-NR/
glass (A): 1 – ZnO-NRs/glass, 2 – BLV-positive’
probe/ZnO-NRs/glass, 3 – BLV-negative’
probe/ZnO-NRs/glass and PAN/ZnO-NR/glass
(B): 1 – PAH/ZnO-NRs/glass, 2 – BLV-positive’
probe/PAH/ZnO-NRs/glass, 3 – BLV-negative’
probe/PAH/ZnO-NRs/glass. The curves are
average of 3 measurements at each stage of
modiﬁcation.
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same concentration level has increased up to 10%.
It is worth to mention, that the direct and polyelectrolyte – PAH –
assisted immobilization of BLV-antigens on the ZnO-NR/glass surface
provided to gp51&BSA/ZnO-NR/glass-based immunosensor advanced
sensitivity against BLV antibodies [18]. However, random orientation
of BLV-antigens signiﬁcantly reduced the sensitivity of gp51&BSA/ZnO-
NR/glass-based immunosensor towards anti-gp51 antibodies and ana-
lytical signal saturation was observed even at the dilution of ‘BLV-po-
sitive’ serum at 1:10,000. Contrary to this, gp51&BSA/PAH/ZnO-NR/
glass-based immunosensor showed good linearity of signal in the serum
dilution range of 1:1,000,000 – 1:1000 of ‘BLV-positive’. The developed
gp51&BSA/PAH/ZnO-NR/glass-based immunosensor can well diﬀer-
entiate ‘BLV-positive’, and ‘BLV-negative’ serums in relatively high di-
lution range from 1:1000 to 1:100,000. Selectivity tests of gp51&BSA/
ZnO-NR/glass- and gp51&BSA/PAH/ZnO-NR/glass-based sensors are
represented supplementary material ﬁgure S2.
4. Conclusion
Novel photoluminescence system based on gp51&BSA/ZnO-NR/
glass- and gp51&BSA/PAH/ZnO-NR/glass-based immunosensor for the
express detection of speciﬁc antibodies against BLV protein gp51 has
been reported. The system is able to discriminate between ‘BLV-posi-
tive’ and ‘BLV-negative’ blood serum probes in the dilution range from
1:1000 to 1:100,000. The proposed mechanism of PL-signal generation
is mostly based on electrostatic interaction between immobilized/in-
teracting biomolecules and ZnO-NRs.
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